Abstract
Objective: One of the most important problems of modern neuropharmacology is a development of new routes for pharmacological correction of cerebral strokes, as a reason of significant increase in morbidity, steady loss of working efficiency and heavy mortality [1, 2]. Ischemic stroke is a multifactor pathological process and occurs primarily in the midst of a mismatch of blood supply level and metabolic brain tissue processes. Medications of secondary neuroprotection (antioxidants, metabolotropic and nootropic drugs, and neuropeptides) take important place in the treatment of ischemic stroke. Nowadays the antioxidant mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) is widely used in clinical practice as a neuroprotector. However, its influence on morphofunctional state of neurons and genome response hadn’t been studied yet. The aim of the current study is to evaluate the neuroprotective activity of mexidol by its ability to influence the mode of immediate early response genes’ expression and morphofunctional neuron parameters. Methods: Research has been carried out on sufficient number of experimental rats. For morphological and histoimmunochemical study brain tissue of experimental animals was used. We studied: cell composition in the area of IV-V cortex layers; density, area and RNA concentration of normal, apoptotically and destructively changed neurons. Results: Modeling of ischemic brain damage led to significant change in genome response which was manifested by an impairment of a mode of expression of immediate early response gene c-fos. Administration of mexidol (250 mg/kg) caused neuroprotective effect. Conclusions: Intraperitoneal administration of mexidol for 21 days after arteria carotis communis occlusion increases c-fos gene expression, thus showing neuroprotective action of the drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.